Pelthos Therapeutics
Price & Volume
Stats
See moreOpen | $24 |
Previous Close | $24 |
Day Range | $24-$24 |
52W Range | $9-$37.50 |
Shares Short | 0 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
News
See moreYahoo Finance • 2 days ago
Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag
Yahoo Finance • 3 months ago
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
Yahoo Finance • 3 months ago
Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI™ (berdazimer) Topical Gel, 10.3%
Yahoo Finance • 4 months ago
Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results
About
CEO | Mr. Scott M. Plesha |
CFO | Mr. Francis Knuettel II, M.B.A. |
Address | 4020 Stirrup Creek Drive, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
